Companies in which arba holds a continued interest include:

TeleMessage enables anyone, anywhere to send, receive and reply to short messages to and from any communication device. more... Picom provides a Content Integration & Delivery software solution geared primarily for insurance companies.  Picom solutions analyze information and deliver a unified view to multiple users such as employees, agents and agencies securely using portal technology, the ACORD XML standard and other leading integration components. more... Visionix provides proprietary optical analysis and mapping technology. The first commercial application is mapping of multi-focal lenses and the second is 3D technology that models human face structures, and additional applications are in the pipeline. more... MMRI has developed the technology for ultra-fast optical disk drives for re-writable, removable, optical media that provide 20-100 times faster access than any conventional known optical drive technology. more... Establishment in 1993, Eldat is focusing exclusively on the development of wireless communication-based in-store solutions for the retail market. more... Clear Audio technology dramatically improves intelligibility of voice in high ambient noise conditions at the receiver’s end. It is not a noise reduction solution at the transmitter side of the conversation. more... (web site under construction) Development of low molecular weight compounds for control of autoimmune diseases. The market for these drugs is estimated at $40 billion annually. Arba represented the investors to acquire the rights to this project under the management of Prof. Shimon Slavin at the Hadassah Medical Center in Jerusalem.